Calcitriol Injection

[Indications] It is suitable for the treatment of secondary hyperparathyroidism associated with chronic kidney disease, especially in patients undergoing hemodialysis, and for the regulation of calcium and phosphorus metabolism disorders caused by vitamin D deficiency or impaired vitamin D activation.

[Usage and dosage] This product is administered by intravenous injection, usually after dialysis. The usual initial dose for adult patients is 0.5–1 μg three times weekly. The dose may be adjusted according to serum calcium, phosphorus, and parathyroid hormone levels. The maximum dose should be determined according to the patient's response and laboratory monitoring. Monitor serum calcium and phosphorus levels regularly during treatment to prevent hypercalcemia.